Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma

CD47 plays the pivotal role in the immune evasion of PEL cells in body cavities. Therapeutic antibody targeting of CD47 could be an effective therapy for PEL.